https://european-biotechnology.com/wp-content/uploads/2024/04/BGV_KevinSchneider_Pixabay.jpg8531280Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-24 07:00:002020-06-24 07:00:00BioGeneration Ventures closes BGV IV Fund at €105m
OneProjects Ltd, an Irish-German cardiac imaging specialist, has closed an €11m Series A financing led by Amsterdam-headquartered life sciences investor LSP.
https://european-biotechnology.com/wp-content/uploads/2024/04/OneProjects.jpeg330660Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-24 06:15:002020-06-24 06:15:00LSP leads €11m Series A round in OneProject
Illumina has opened its first accelerator outside the US in Cambridge to fund genomics start-ups. Meanwhile, Epidarex Capital has raised £102m for UK biotechs.
https://european-biotechnology.com/wp-content/uploads/2024/04/flag-1192625_1920.jpg9601920Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-22 10:59:262020-06-22 10:59:26Illumina and Epidarex Capital invest in post-Brexit UK
Researchers from Italy, Denmark and the UK have devised a new vaccination strategy to tackle hepatitis C and boosting the required strong T cell response.
https://european-biotechnology.com/wp-content/uploads/2024/04/HCV.jpg393562Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-18 06:24:002020-06-18 06:24:00Novel adjuvant teases T cells to respond to HCV
https://european-biotechnology.com/wp-content/uploads/2024/04/novel-coronavirus-sars-cov-2_49680384436_o.jpg18011800Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-17 09:08:432020-06-17 09:08:43First drug found to reduce COVID-19-mortality
https://european-biotechnology.com/wp-content/uploads/2024/04/Curevac-vaccine_printer.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-16 08:32:092020-06-16 08:32:09Germany puts €300m in CureVac AG for COVID-19 vaccine
/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png00h.genrich/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngh.genrich2020-06-12 12:53:522020-06-12 12:53:52New CEO at Ipsen
Emperor Nero, reportedly, fiddled as Rome burned in 64 A.D., much like society for a long time ignored and repressed the pending crisis of antimicrobial resistance (AMR).
https://european-biotechnology.com/wp-content/uploads/2024/04/AiCuris_PREP_kl.jpg239425Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-12 11:36:002020-06-12 11:36:00Antimicrobial resistance This is not the time to wait. This is the time to act.
https://european-biotechnology.com/wp-content/uploads/2024/04/Genmab.jpg387568Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2020-06-10 12:45:032020-06-10 12:45:03Abbvie and Genmab team up in oncology
BioGeneration Ventures closes BGV IV Fund at €105m
Latest NewsBioGeneration Ventures has closed its fourth VC fund for European start-ups (BGV IV) at €105m.
LSP leads €11m Series A round in OneProject
Latest NewsOneProjects Ltd, an Irish-German cardiac imaging specialist, has closed an €11m Series A financing led by Amsterdam-headquartered life sciences investor LSP.
Illumina and Epidarex Capital invest in post-Brexit UK
Latest NewsIllumina has opened its first accelerator outside the US in Cambridge to fund genomics start-ups. Meanwhile, Epidarex Capital has raised £102m for UK biotechs.
Biognosys appoints new Chairman
AppointmentsSchlieren-based proteomics specialist Biognosys AG announces the appointment of Dr Patrick Vink as Chairman of the board.
Novel adjuvant teases T cells to respond to HCV
Latest NewsResearchers from Italy, Denmark and the UK have devised a new vaccination strategy to tackle hepatitis C and boosting the required strong T cell response.
First drug found to reduce COVID-19-mortality
Latest NewsA clinical trial has identified the first immuno-modulatory drug to significantly reduce COVID-19 mortality in ventilated patients.
Germany puts €300m in CureVac AG for COVID-19 vaccine
Latest NewsIn the race aimed at securing access to COVID-19 vaccines, Germany has acquired a minority stake in the local mRNA vaccine producer Curevac AG.
New CEO at Ipsen
AppointmentsDavid Loew, formerly executive vice president of Sanofi Pasteur, was appointed as CEO of French Ipsen Pharma SA at the beginning of July.
Antimicrobial resistance This is not the time to wait. This is the time to act.
Sponsored PublicationsEmperor Nero, reportedly, fiddled as Rome burned in 64 A.D., much like society for a long time ignored and repressed the pending crisis of antimicrobial resistance (AMR).
Abbvie and Genmab team up in oncology
Latest NewsAbbVie is partnering with Genmab A/S to commercialise up to seven new antibody formats.